Bluescope Steel – Accumulation Range
BlueScope Steel is under Algo Engine buy signals and the chart below shows the suggested accumulation range.

BlueScope Steel is under Algo Engine buy signals and the chart below shows the suggested accumulation range.
BlueScope Steel is under Algo Engine buy conditions.
With $285M of stock bought since August 2021, the Board has approved an increase in the scale of the buy-back program to allow up to a further $700 million to be bought over the next 12 months
BlueScope delivers record underlying EBIT of $2.20Bn, increases on-market buy-back; commences feasibility, analysis on blast furnace reline at Port Kembla
1H FY2022 Headlines
Reported NPAT: $1.64Bn
Underlying NPAT: $1.57Bn
Underlying EBIT: $2.20Bn
2H FY2022 GROUP OUTLOOK: Underlying EBIT in 2H FY2022 is expected to be in the range of $1.20 billion to $1.35 billion.
BlueScope Steel is under Algo Engine buy conditions.
BlueScope Steel is under Algo Engine buy conditions.
BlueScope Steel is under Algo Engine buy conditions.
MCHP:NAS was added to our NASDAQ 100 model portfolio on 28/3/2019 at $81.15. The position was closed yesterday for a 90.95% gain after an 868-day holding period.
To review the current holdings of other stocks in our models, please login or start your free trial today
BlueScope Steel was added to our ASX 100 model portfolio on 28/1/21 at $16.03. The share price is now up 60.80% after a 197-day holding period.
The stock remains under Algo Engine buy conditions.
To review the current holdings of other stocks in our ASX 100 model, please login or start your free trial today
BlueScope Steel earnings have been upgraded across all segments, which have seen strong volumes and improving steel spreads in Australia and the US.
BSL expects to report 1H21 EBIT of A$530m. The stock has switched to Algo Engine buy conditions and we see support building within the $14.50 to $16 price range.
BlueScope Steel is under Algo Engine buy conditions and we see the current selloff as a buying opportunity.
BSL reported net profit fell 70% to $186 million 2H19 from $624 million on the same time last year. Revenue dropped 8% to $5.8bn from $6.4bn.
EBIT fell 64% $302 million from the year-earlier $850 million.
The company indicated EBIT in the 1H20, had renewed caution because of the uncertain impact from coronavirus on its businesses and customers.
Value is likely to emerge near the $12.50 price level. We add this to our watchlist
Or start a free thirty day trial for our full service, which includes our ASX Research.